Two-year results of realise-a postmarketing observational study: Effectiveness and safety of adalimumab (humira (R)) is maintained in patients with rheumatoid arthritis (ra)

ANNALS OF THE RHEUMATIC DISEASES(2007)

Cited 0|Views5
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined